Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

被引:314
作者
Oravecz, T
Pall, M
Roderiquez, G
Gorrell, MD
Ditto, M
Nguyen, NY
Boykins, R
Unsworth, E
Norcross, MA
机构
[1] NIH,DIV HEMATOL PROD,CTR BIOL EVALUAT & RES,FDA,BETHESDA,MD 20892
[2] US FDA,DIV ALLERGEN PROD & PARASITOL,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892
[3] US FDA,FACIL BIOTECHNOL RESOURCES,CTR BIOL EVALUAT & RES,BETHESDA,MD 20892
[4] ROYAL PRINCE ALFRED HOSP,AW MORROW GASTROENTEROL & LIVER CTR,NEWTOWN,NSW 2042,AUSTRALIA
[5] UNIV SYDNEY,CENTENARY INST CANC MED & CELL BIOL,NEWTOWN,NSW 2042,AUSTRALIA
关键词
D O I
10.1084/jem.186.11.1865
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD26 is a leukocyte activation marker that possesses dipeptidyl peptidase IV activity but whose natural substrates and immunological functions have not been clearly defined. Several chemokines, including RANTES (regulated on activation, normal T cell expressed and secreted), have now been shown to be substrates for recombinant soluble human CD26. The truncated RANTES(3-68) lacked the ability of native RANTES(1-68) to increase the cytosolic calcium concentration in human monocytes, but still induced this response in macrophages activated with macrophage colony-stimulating factor. Analysis of chemokine receptor messenger RNAs and patterns of desensitization of chemokine responses showed that the differential activity of the truncated molecule results from an altered receptor specificity. RANTES(3-68) showed a reduced activity, relative to that of RANTES(1-68), with cells expressing the recombinant CCR1 chemokine receptor, but retained the ability to stimulate CCR5 receptors and to inhibit the cytopathic effects of HIV-1. Our results indicate that CD26-mediated processing together with cell activation-induced changes in receptor expression provides an integrated mechanism for differential cell recruitment and for the regulation of target cell specificity of RANTES, and possibly other chemokines.
引用
收藏
页码:1865 / 1872
页数:8
相关论文
共 36 条
[1]  
ALKAHATIB G, 1996, SCIENCE, V272, P1955
[2]   HIV blocked by chemokine antagonist [J].
ArenzanaSeisdedos, F ;
Virelizier, JL ;
Rousset, D ;
ClarkLewis, I ;
Loetscher, P ;
Moser, B ;
Baggiolini, M .
NATURE, 1996, 383 (6599) :400-400
[3]   A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains [J].
Berson, JF ;
Long, D ;
Doranz, BJ ;
Rucker, J ;
Jirik, FR ;
Doms, RW .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6288-6295
[4]  
BLEUL CC, 1996, NATURE, V382, P839
[5]   VIRAL DETERMINANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 T-CELL OR MACROPHAGE TROPISM, CYTOPATHOGENICITY, AND CD4 ANTIGEN MODULATION [J].
CHENGMAYER, C ;
QUIROGA, M ;
TUNG, JW ;
DINA, D ;
LEVY, JA .
JOURNAL OF VIROLOGY, 1990, 64 (09) :4390-4398
[6]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[7]  
DAVIS SJ, 1990, J BIOL CHEM, V265, P10410
[8]   Identification of a major co-receptor for primary isolates of HIV-1 [J].
Deng, HK ;
Liu, R ;
Ellmeier, W ;
Choe, S ;
Unutmaz, D ;
Burkhart, M ;
DiMarzio, P ;
Marmon, S ;
Sutton, RE ;
Hill, CM ;
Davis, CB ;
Peiper, SC ;
Schall, TJ ;
Littman, DR ;
Landau, NR .
NATURE, 1996, 381 (6584) :661-666
[9]   A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors [J].
Doranz, BJ ;
Rucker, J ;
Yi, YJ ;
Smyth, RJ ;
Samson, M ;
Peiper, SC ;
Parmentier, M ;
Collman, RG ;
Doms, RW .
CELL, 1996, 85 (07) :1149-1158
[10]   HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5 [J].
Dragic, T ;
Litwin, V ;
Allaway, GP ;
Martin, SR ;
Huang, YX ;
Nagashima, KA ;
Cayanan, C ;
Maddon, PJ ;
Koup, RA ;
Moore, JP ;
Paxton, WA .
NATURE, 1996, 381 (6584) :667-673